Expanded Approval For J&J HIV Drug Granted By FDA

October 23, 2008

The U.S. Food and Drug Administration (FDA) has announced that they have approved the Johnson & Johnson drug  Prezista for expanded use of the treatment of HIV..............Washington (ChattahBox) – The U.S. Food and Drug Administration (FDA) has announced that they have approved the Johnson & Johnson drugĀ  Prezista for expanded use of the treatment of HIV.

Prezista is a drug that has been used in the past in combination with other HIV drugs.

The drug was, in the past, used when patients had already developed resistance to protease inhibitors.

The FDA has expanded their approval of the drug though as it will now apply to patients who have just been diagnosed with HIV.

With the approval, HIV patients have another first-line option to battle their disease.

The company recommends that the drug be taken with Ritonavir, sold by Abbott Laboratories under the name Norvir.

The FDA listed common side effects as diarrhea, nausea, headache, skin rashes.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.